Position in MRK
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$2,767,761
+$119,939 QoQ
Shares Held
21,539
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.27%
of 13F equity value
Holder Rank
#1,386
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First PREMIER Bank holds $19,058,988 across 11 Drug Manufacturers - General names. MRK ranks #3 (14.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
36,024 | $9,149,013 | |
| 2 | AMGN |
Amgen Inc
|
8,903 | $3,223,954 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
21,539 | $2,767,761 | |
| 4 | ABBV |
AbbVie Inc.
|
6,697 | $1,685,232 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
5,692 | $719,126 | |
| 6 | LLY |
ELI LILLY & Co
|
538 | $645,292 | |
| 7 | PFE |
Pfizer Inc
|
15,632 | $376,417 | |
| 8 | GSK |
GSK plc
|
4,433 | $232,377 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,767,761 | 21,539 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $2,647,822 | 22,012 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $2,370,454 | 22,520 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,925,605 | 22,943 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $1,888,598 | 23,858 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $2,211,596 | 24,639 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $2,611,149 | 26,248 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $3,090,760 | 27,217 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $3,444,734 | 27,825 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $3,677,708 | 27,872 | Shares | Other | 2024-04-12 | |
| 2023-12-31 | $3,109,247 | 28,520 | Shares | Other | 2024-01-17 | |
| 2023-09-30 | $2,936,132 | 28,520 | Shares | Other | 2023-10-16 | |
| 2023-06-30 | $3,353,347 | 29,061 | Shares | Other | 2023-07-13 | |
| 2023-03-31 | $3,098,819 | 29,127 | Shares | Other | 2023-04-10 | |
| 2022-12-31 | $3,275,020 | 29,518 | Shares | Other | 2023-01-17 | |
| 2022-09-30 | $2,563,188 | 29,763 | Shares | Other | 2022-10-20 | |
| 2022-06-30 | $2,711,210 | 29,738 | Shares | Other | 2022-07-26 | |
| 2022-03-31 | $2,423,673 | 29,539 | Shares | Other | 2022-04-25 | |
| 2021-12-31 | $2,272,680 | 29,654 | Shares | Other | 2022-01-19 | |
| 2021-09-30 | $2,229,938 | 29,689 | Shares | Other | 2021-10-12 | |
| 2021-06-30 | $2,292,579 | 29,479 | Shares | Other | 2021-07-14 | |
| 2021-03-31 | $2,181,569 | 28,299 | Shares | Other | 2021-04-12 | |
| 2020-12-31 | $2,314,853 | 28,299 | Shares | Other | 2021-01-12 | |
| 2020-09-30 | $2,300,534 | 27,734 | Shares | Other | 2020-10-06 | |
| 2020-06-30 | $2,154,722 | 27,864 | Shares | Other | 2020-07-07 | |
| 2020-03-31 | $2,036,984 | 26,475 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||